Helping transform medical discovery and innovation into viable solutions that can impact the world

Dr. Mickey S. Urdea will participate in the CROI Conference in Seattle, Washington. The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. The CROI Foundation partners with the International Antiviral Society–USA (IAS–USA) for organization of the conference.

Mr. Richard M. Thayer will attend the Digital Health: Sensors, Wearables and IoT program of the Molecular Diagnostics Strategy and Outlook Executive Summit, part of the Molecular Medicine Tri-Conference in San Francisco, California. Molecular diagnostics along with healthcare in general are undergoing technology-driven revolution. Novel detection assays and sensors, digital biomarkers and machine learning approaches have become key drivers for innovation in drug development and patient care. This channel will feature the latest technology breakthroughs as well as partnering, regulatory and reimbursement solutions for implementation into value-based patient-centered care.

Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 71^st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California. AACC provides an unparalleled opportunity to connect with global leaders in laboratory medicine and to discover cutting edge technology and learn about vital research in the field. AACC is the meeting place for global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

Download the Report

Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California.  The JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2019, more than 450 companies, both public and private, are set to deliver presentations to more than 9,000 attendees.